Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

Clinical trial NCT02675829 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02675829
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Cancers Lung Cancer Bladder Cancer Urinary Tract Cancers

Start date: 2016-02-01
Primary completion: 2027-02-01
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.